Income Statement

Fundamentals - Annual Income Statement

  Year Ending Dec 2017 (Update) Year Ending Dec 2016 (Update) Year Ending Dec 2015 (Update) Year Ending Dec 2014 (Update) Year Ending Dec 2013 (Update)
Net Sales 1.67M 1.58M 1.54M 1.46M 1.41M
Revenue 1.67M 1.58M 1.54M 1.46M 1.41M
Total Revenue 1.67M 1.58M 1.54M 1.46M 1.41M
Cost of Revenue 1.15M 1.12M 1.09M 1.03M 1.01M
Cost of Revenue, Total 1.15M 1.12M 1.09M 1.03M 1.01M
Gross Profit 516.19 461.45 455.78 421.61 404.52
Selling/General/Administrative Expense 258.03 234.32 225.18 212.29 204.09
Labor & Related Expense 4.99 1.93 7.52 2.57 1.30
Selling/General/Administrative Expenses, Total 263.03 236.25 232.70 214.86 205.39
Depreciation 35.49 34.28 32.37 29.88 27.70
Amortization of Intangibles, Operating 0.14 0.36 1.13 3.19 4.69
Depreciation/Amortization 35.63 34.64 33.50 33.07 32.39
Investment Income - Operating 8.43 2.06 0.15 3.12 4.98
Interest/Investment Income - Operating 8.43 2.06 0.15 3.12 4.98
Interest Expense (Income), Net-Operating, Total 8.43 2.06 0.15 3.12 4.98
Litigation 5.19 5.26 4.97 2.14 2.15
Impairment-Assets Held for Use
Other Unusual Expense (Income)
Unusual Expense (Income) 5.19 5.26 4.97 2.14 2.15
Other Operating Expense -- --
Other, Net 90.88 4.49 -- 26.22
Other Operating Expenses, Total 90.88 4.49 -- -- 26.22
Total Operating Expense 1.55M 1.40M 1.36M 1.29M 1.28M
Operating Income 113.04 178.75 184.46 168.42 133.39
Interest Expense - Non-Operating -4.27 -3.72 -3.65 -8.19 -15.04
Interest Expense, Net Non-Operating -4.27 -3.72 -3.65 -8.19 -15.04
Interest Income, Non-Operating 0.43 0.38 0.28 -0.03 0.85
Investment Income, Non-Operating 8.43 2.06 0.15 3.12 4.98
Interest/Investment Income, Non-Operating 8.86 2.44 0.43 3.09 5.83
Interest Income (Expense), Net-Non-Operating, Total 4.59 -1.27 -3.22 -5.10 -9.21
Gain (Loss) on Sale of Assets -0.71 -0.42 -0.70 -0.64 -0.32
Other Non-Operating Income (Expense) 0.00 -- -0.42 0.07 -0.04
Other, Net 0.00 -- -0.42 0.07 -0.04
Net Income Before Taxes 116.92 177.05 180.13 162.75 123.83
Income Tax – Total 18.74 68.31 69.85 63.44 46.60
Income After Tax 98.18 108.74 110.27 99.32 77.23
Net Income Before Extraordinary Items 98.18 108.74 110.27 99.32 77.23
Discontinued Operations
Total Extraordinary Items
Net Income 98.18 108.74 110.27 99.32 77.23
Income Available to Common Excluding Extraordinary Items 98.18 108.74 110.27 99.32 77.23
Income Available to Common Stocks Including Extraordinary Items 98.18 108.74 110.27 99.32 77.23
Basic Weighted Average Shares 16.06 16.38 16.87 17.17 18.20
Basic EPS Excluding Extraordinary Items 6.11 6.64 6.54 5.79 4.24
Basic EPS Including Extraordinary Items 6.11 6.64 6.54 5.79 4.24
Dilution Adjustment
Diluted Net Income 98.18 108.74 110.27 99.32 77.23
Diluted Weighted Average Shares 16.74 16.79 17.42 17.84 18.59
Diluted EPS Excluding Extraordinary Items 5.86 6.48 6.33 5.57 4.16
Diluted EPS Including Extraordinary Items 5.86 6.48 6.33 5.57 4.16
DPS - Common Stock Primary Issue 1.08 1.00 0.92 0.84 0.76
Gross Dividends - Common Stock 16.44 15.61 14.26 12.54
Stock-Based Compensation, Supplemental 8.33 5.45 4.80
Interest Expense, Supplemental 4.27 3.72 3.65 8.19 15.04
Interest Capitalized, Supplemental
Depreciation, Supplemental 35.49 34.28 32.37 29.88 27.70
Litigation Charge, Supplemental 0.05 0.18 0.45 26.33
Other Unusual Expense (Income), Supplemental 0.04 0.02 0.36
Non-Recurring Items, Total 0.05 0.21 0.47 26.69
Total Special Items 5.90 5.73 5.89 3.25 29.16
Normalized Income Before Taxes 122.82 182.78 186.01 166.01 152.99
Effect of Special Items on Income Taxes 0.95 2.21 2.28 1.27 10.98
Income Taxes Excluding Impact of Special Items 19.69 70.52 72.13 64.70 57.58
Normalized Income After Taxes 103.13 112.26 113.88 101.30 95.41
Normalized Income Available to Common 103.13 112.26 113.88 101.30 95.41
Basic Normalized EPS 6.42 6.85 6.75 5.90 5.24
Diluted Normalized EPS 6.16 6.69 6.54 5.68 5.13
Amortization of Intangibles, Supplemental 0.14 0.36 1.13 3.19 4.69
Rental Expense, Supplemental 40.03 40.02 39.61 38.99
Advertising Expense, Supplemental
Audit-Related Fees, Supplemental 2.05 1.93 1.91 1.89
Audit-Related Fees 0.14 0.13 0.13 0.13
Tax Fees, Supplemental -- -- --
All Other Fees Paid to Auditor, Supplemental -- -- --
Gross Margin 30.97 29.26 29.53 28.95 28.62
Operating Margin 6.78 11.34 11.95 11.57 9.44
Pretax Margin 7.01 11.23 11.67 11.18 8.76
Effective Tax Rate 16.03 38.58 38.78 38.98 37.63
Net Profit Margin 5.89 6.90 7.14 6.82 5.46
Normalized EBIT 126.66 186.12 189.79 174.15 167.22
Normalized EBITDA 162.28 220.75 223.29 207.22 199.61
Current Tax - Domestic 64.70 55.03 48.58 45.35
Current Tax - Foreign 0.39 0.40 0.60 0.51
Current Tax - Local 9.93 8.10 7.29 7.73
Current Tax - Total 75.02 63.53 56.46 53.59
Deferred Tax - Domestic -6.71 6.32 6.97 -7.00
Deferred Tax - Foreign 0.01 0.00 0.01 0.01
Deferred Tax - Total -6.71 6.33 6.98 -6.99
Income Tax - Total 68.31 69.85 63.44 46.60
Defined Contribution Expense - Domestic 14.47 11.97 13.84 14.51
Total Pension Expense 14.47 11.97 13.84 14.51
Number of Discharges 65.64M 64.69M 64.90M 63.48M 63.00M
Net Inpatient Revenues 90.47 97.58 99.44 102.88 104.97
For a more complete picture of our financial results, please review our SEC Filings

In millions of USD (except for per share items)

Copyright Thomson Reuters Corporation

All information current at time of original publication. Read complete disclaimer for details.
Copyright © 2017, Chemed Corporation. All rights reserved.
Page last modified: 04/18/05